RxDoctor Payments Data

Clay Anderson, MD

Family Medicine · Saint Stephen, SCNPI 1386268860

Payments from drug & device makers

$352in general payments, 2019–2025

Across 19 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$59
  • Novo Nordisk$59
  • Seqirus USA Inc$49
  • Pfizer$47
  • Otsuka America Pharmaceutical, Inc.$27
  • Tolmar, Inc.$20
  • plus $91 from 6 others

What the payments were for

  • Food & beverage$352100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$352 in reported general payments places this provider in the 40th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$286,936
Medicare patients
332
Services billed
10,840

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin161$103,999
OzempicSemaglutide102$99,276
EliquisApixaban101$71,736
JanuviaSitagliptin Phosphate90$66,342
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$51,396
MounjaroTirzepatide41$49,200
FarxigaDapagliflozin Propanediol76$48,288
LinzessLinaclotide45$27,605
TrulicityDulaglutide24$26,336
MyrbetriqMirabegron37$18,315
Synjardy XrEmpagliflozin/Metformin Hcl21$18,093
InvokanaCanagliflozin26$14,988
Janumet XrSitagliptin Phos/Metformin Hcl16$12,484
SymbicortBudesonide/Formoterol Fumarate38$10,366
Bydureon BciseExenatide Microspheres12$9,315

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta$17$129,307193 claims
Novo NordiskOzempic$59$99,276102 claims
PfizerEliquis, Premarin$47$75,409112 claims
GSKTrelegy Ellipta, Breo Ellipta$59$57,00668 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$13$6,52911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Saint Stephen

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →